[Form 4] PRECIGEN, INC. Insider Trading Activity

Rhea-AI Filing Summary

PRECIGEN, INC. director Vinita D. Gupta reported the vesting and exercise of restricted stock units into common shares. On March 13, 2026, 71,839 RSUs, each representing the right to receive one share of Precigen common stock, vested in full and were converted into 71,839 common shares at no exercise price. Following this transaction, Gupta holds 666,027 shares of Precigen common stock directly, reflecting a routine compensation-related equity acquisition rather than an open-market purchase or sale.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gupta Vinita D

(Last) (First) (Middle)

20374 SENECA MEADOWS PARKWAY

(Street)

GERMANTOWN MD 20876

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/13/2026		M		71,839	A	(1)	666,027	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	03/13/2026		M			71,839	(2)	(2)	Common Stock	71,839	$0	0	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.

2. The RSUs vested in full on March 13, 2026.

	/s/ Vinita D. Gupta, by Donald P. Lehr, as attorney-in-fact	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Vinita D. Gupta report for PRECIGEN (PGEN)?

Director Vinita D. Gupta reported the vesting and exercise of 71,839 restricted stock units into an equal number of PRECIGEN common shares. This was a compensation-related equity award, not an open-market stock purchase or sale.

How many PRECIGEN (PGEN) shares does Vinita D. Gupta hold after this Form 4 filing?

After the reported RSU vesting and conversion, Vinita D. Gupta directly holds 666,027 PRECIGEN common shares. This position reflects her ownership following the acquisition of 71,839 shares from fully vested restricted stock units on March 13, 2026.

Was the PRECIGEN (PGEN) Form 4 transaction an open-market buy or sell?

The Form 4 does not show any open-market buy or sell. It reports a derivative exercise where 71,839 restricted stock units vested and converted into common shares at a zero exercise price as part of Gupta’s equity compensation.

What do the restricted stock units in the PRECIGEN (PGEN) filing represent?

Each restricted stock unit in the filing represents a contingent right to receive one share of PRECIGEN common stock. These RSUs vested in full on March 13, 2026, triggering delivery of 71,839 common shares to director Vinita D. Gupta.

Does the PRECIGEN (PGEN) Form 4 indicate remaining derivative holdings for Vinita D. Gupta?

The filing’s derivative summary is empty, indicating no remaining derivative securities such as unvested RSUs or options are shown for this report. The 71,839 RSUs vested in full and were fully converted into common shares on March 13, 2026.

How is the RSU vesting date described in the PRECIGEN (PGEN) Form 4 footnotes?

The footnotes state that the restricted stock units vested in full on March 13, 2026. Upon vesting, each RSU provided one share of PRECIGEN common stock, resulting in 71,839 new shares for director Vinita D. Gupta.